Non-functioning pancreatic neuroendocrine tumor
Clinical trials for Non-functioning pancreatic neuroendocrine tumor explained in plain language.
Never miss a new study
Get alerted when new Non-functioning pancreatic neuroendocrine tumor trials appear
Sign up with your email to follow new studies for Non-functioning pancreatic neuroendocrine tumor, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise in slowing advanced neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose cancer worsened after prior treatment will receive either cabozantinib or a placebo pill. The main goal …
Matched conditions: NON-FUNCTIONING PANCREATIC NEUROENDOCRINE TUMOR
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Tiny DNA fragments in blood could reveal how aggressive a pancreatic tumor will be
Diagnosis OngoingPancreatic neuroendocrine tumors behave unpredictably: some stay slow for years while others spread quickly, and doctors lack reliable tests to tell them apart before surgery. This study examines cell-free DNA, tiny genetic fragments shed by tumors into the bloodstream, from abou…
Matched conditions: NON-FUNCTIONING PANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Massimo Falconi • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC